Range of suitable people: CDEC mentioned the uncertainty in the amount of clients with moderately severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some clients that are categorized as having mild or reasonable illness could have a severe bleeding phenotype, https://bobbya599bde4.luwebs.com/profile